The Pharmaceutical Market: Taiwan

Publication Date	March 2007
Publisher	Espicom
Product Type	Report
Pages	106
ISBN Number	not applicable
Product Code	ESP00021

Price

£595.00
approximately: $869 | €652

PDF

PRINT £595 ($869 | €652)

Order above formats by FAX

Summary

Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Portugal has a small pharmaceutical market, valued at US$5.9 billion at retail prices in 2007. One of the weaknesses of the Portuguese pharmaceutical market is the lack of national policies for the industry and difficulties in applying innovation. Local producers are small and need to merge or form alliances to compete at European and global levels. There are 15 leading local producers which are responsible for one third of total domestic production.

A new pharmacy regulatory environment was established in August 2007. Since March 2007, a new drug price system has also been in place. In 2006, Portugal transposed its national regulation for human pharmaceuticals to the relevant European Directives. Other measures in 2006 included new rules to purchase hospital medicines.

Since being in power in 2005, the Socialist party has adopted other measures to promote the access of drugs among the population. These include the sale of non-prescription medicines (MNSRM), that are not reimbursed by the government, in establishments different from pharmacies; price reductions of 6% in reimbursed drugs; cancellation of the extra 10% reimbursement of generics; and the revision of the existing reimbursement system.

The number of pharmacies has increased moderately in recent years. In 2005, there were 2,775 pharmacies in Portugal, of which 2,670 were in the mainland, 46 in Azores and 59 in Madeira. Also, there were 259 pharmacy extensions in 2005, of which 239 were in the mainland, 19 in Azores and one in Madeira. Excluding Azores and Madeira, there were 305 wholesalers in 2005, which represented an increase of 14.2% over 267 wholesalers in 2005.

Please Note: The publisher will not fulfil orders to a personal email address, you must supply a work or business address.

Content

Geography
Political Overview
Economic Overview
- Economic Indicators 2007-2012
Population
- Population, 1994-2005
- Population of Major Cities, 2000-2005
- Population Projections
- Projected Population, 2007-2051
Demographic Indicators
- Principal Demographic Indicators, 1996-2005
Mortality
- Major Causes of Death, 2001-2005
- Cancer Deaths
- Male Cancer Deaths, 2001-04
- Female Cancer Deaths, 2001-04
Morbidity
- Communicable Diseases
- Reported Infectious Diseases, 2001-2005 (Confirmed Cases)
Charts
- Map of Taiwan
- Population by Age Group, 2005 (%)
- Projected Population, 2007-2051
Organisation & Administration
- Medical Care Network
- National Health Insurance Programme
Health Expenditure
- Total Healthcare Expenditure, 1991-2005
- Health Expenditure by Type, 2005
- Health Expenditure by Type, 1991-2005 (NT$ millions)
Hospital Services
- Hospitals and Beds, 1997-2005
- Hospitals and Beds by Region, 2005
- Hospitals and Beds by Sector, 2005
- Beds by Specialty, 2005
- Accredited hospitals
- Hospitals by Accreditation, 2005
- Hospital Activity
- Daily Average Inpatient Discharges and Operations, 1997-2005
- Daily Average Discharges and Operations by County/City, 2002
- ALOS and Bed Occupancy, 2002
- Nursing Care
Ambulatory Care
- Number of Clinics, 1988-2005
- Clinics by Region, 2005
- Clinics by Type/Owner, 2002
- Daily Average Outpatient Visits, 1995-2005
Medical Personnel
- Medical Personnel, 2001-05
- Medical Personnel, 2001-2005 (Rate/000 population)
- Physicians
- Number of Physicians, 1988-2005
- Physicians by Region, 2005
- Physicians by Workplace, 2002
- Specialists working in hospitals by ownership and type, 2005
- Dentists
- Number of Dentists, 1988-2005
- Dentists by Region, 2005
Introduction
Regulatory Environment
- Pharmaceutical Registration/Drug Approval Process
- Free Sales Certificates
- Plant Master File
- Good Manufacturing Practice
- Clinical Trials
- Drug testing
- Surveillance System
- Drug Relief Injuries Fund
- Patent Protection & Intellectual Property Rights
- New Data Protection Law
- Pharmaceutical Pricing and Reimbursement
- Over 5,000 drug prices lowered in 2006
- Background
- Patient co-payments
Distribution Channels
- Wholesaling
- Dispensing
Trade Fairs
- Mediphar
Domestic Production
- Registered Western Medicine Manufacturers, 1990-2005
- China Chemical & Pharmaceutical Co Ltd (CCPC)
- China Chemical Synthesis Industrial Co Ltd (CCSI)
- Dah Feng Capsule Industry Co Ltd
- Everlight Chemical Industrial Company
- Formosa Laboratory
- Genovate Biotechnology Co Ltd
- Leily Biotech
- Nan Kuang Pharmaceutical
- Newai Chemical Industry Co Ltd
- ScinoPharm
- Sinphar Pharmaceuticals
- Syn-Tech Chem & Pharm Co Ltd
Taiwan Accessing The Pharmaceutical Market
- Shin Lih Fang Enterprise Co Ltd
- Sintong Chemical Industrial Co
- Taiwan Panbiotic
- Ying Yuan Chemical Pharmaceutical Co Ltd
- Weidar Chemical & Pharmaceutical Co Ltd
- Yung Shim Pharm Ind Co Ltd
- Multinational Activity
Irpma
- Research & Development
Directory
- Healthcare Organisations
- Trade Associations